Story at a glance
- The company on Tuesday announced it will start selling its exclusive private-label version of analog insulin, ReliOn NovoLog, in pharmacies this week to customers with a prescription.
- The drug will be available in Sam’s Club pharmacies in July.
- Walmart claims their option will save customers between 58 to 75 percent compared to branded products.
Retail giant Walmart is launching its own less expensive version of insulin it says will “revolutionize the access and affordability to diabetes care.”
The company on Tuesday announced it will start selling its exclusive private-label version of analog insulin, ReliOn NovoLog, in pharmacies this week to customers with a prescription. The drug will be available in Sam’s Club pharmacies in July.
The insulin will cost just roughly $73 for a vial and about $86 for pre-filled insulin pens. Walmart claims their option will save customers between 58 to 75 percent compared to branded products, a savings of up to $101 for branded vials, or $251 per package of branded FlexPens.
READ MORE STORIES FROM CHANGING AMERICA
SCIENTISTS INVENT PACEMAKER THAT DISSOLVES IN YOUR BODY
CONTROVERSY EXPLODES OVER ALZHEIMER’S DRUG APPROVAL
FDA APPROVES BIOGEN’S NEW ALZHEIMER’S DRUG, THE FIRST IN NEARLY TWO DECADES
FDA APPROVES WEIGHT LOSS DRUG FOR THE FIRST TIME IN SEVEN YEARS
YOUNGER CHILDREN WITHIN A CLASS MORE LIKELY TO HAVE LEARNING DISORDER DIAGNOSIS
“We know many people with diabetes struggle to manage the financial burden of this condition, and we are focused on helping by providing affordable solutions. We also know this is a condition that disproportionately impacts underserved populations,” Cheryl Pegus, executive vice president of Walmart Health and Wellness, said in a release.
“With ReliOn NovoLog insulin, we’re adding a high-quality medication for diabetes to the already affordable ReliOn line of products and continuing our commitment to improve access and lowering cost of care,” Pegus said.
The drug is the latest addition to the retailer’s private brand of diabetes products called ReliOn. The insulin will be manufactured by pharmaceutical company Novo Nordisk.
While insulin has been used as medication for about a century, no generic versions of the drug have been made available.
America is changing faster than ever! Add Changing America to your Facebook or Twitter feed to stay on top of the news.
Medical costs for treating diabetes are estimated at around $9,601 per person each year, according to American Diabetes Association CEO Tracey D. Brown.
“We welcome all affordable solutions that make diabetes management more accessible to millions of Americans living with diabetes,” Brown said in a statement.
More than 34 million people in the U.S. have diabetes, and more than 88 million have prediabetes. The number of adults diagnosed with diabetes has more than doubled in the last 20 years.
READ MORE STORIES FROM CHANGING AMERICA
FOLLOW-UP STUDY FINDS A SINGLE DOSE OF ONE DRUG CAN EASE ANXIETY AND DEPRESSION FOR FIVE YEARS
COMBINATION OF DRUGS PROMISING FOR BRAIN TUMOR TREATMENT
OBAMACARE DRAWS 200K NEW SIGNUPS
NEW PSYCHEDELICS STUDY SUGGESTS PLACEBO WORKS TOO
PSYCHOLOGICAL EFFECTS OF THE PANDEMIC MAY BE FELT IN YOUNG PEOPLE FOR A LONG TIME TO COME
SLEEPING AND WAKING ONE HOUR EARLIER CUTS RISK OF DEPRESSION: STUDY
changing america copyright.
